EU awards large funding to develop data-driven collaboration between European Pediatric Hospitals
PHEMS project will advance data-driven research and innovation activities in pediatrics and the use of privacy-preserving datasets in Europe. The project’s aim is to overcome important barriers that currently hinder cross-border collaboration on health data by developing and validating a decentralized health data ecosystem. This will enable an ecosystem without central data repositories or release of sensitive personal health data from hospitals.

A consortium led by HUS Helsinki University Hospital has received significant EU funding for developing data collaboration between European Children’s Hospitals in a privacy-preserving manner. Progress in this area will help the development of new therapies for children, the assessment of pediatric care outcomes and the advancement of new technology solutions such as artificial intelligence in pediatrics. The project will start in October 2023 and go on until September 2026. It has been awarded a total funding of 7 M€ from the Horizon Europe programme and from the UK research funding agency.
“We will enable European collaboration on health data by aligning ethical and legal requirements of leading European pediatric hospitals with the needs of data users. This ensures that researchers can benefit from rich datasets and advance scientific research in pediatrics while the patient’s rights and data privacy remain protected” states Katariina Gehrmann, Director of Digital and Innovation Services at HUS New Children’s Hospital.
To achieve this, the project develops new technological solutions that facilitate authorized access to health data at multiple locations and advances federated health data analysis together with next-generation anonymization. In addition, the project develops shared rules and governance structures, which allow new partners to join and new datasets to be included in the ecosystem.
“One challenge with algorithmically anonymized and synthetized datasets is the lack of evidence on their validity and utility for real-world needs in research or healthcare management. Therefore, we shall perform studies on three clinical use cases and aim to generate evidence in different clinical areas and in the management of healthcare operations” continues Gehrmann.
The Consortium consists of six leading European pediatric hospitals from the European Children's Hospital Organization (ECHO) community and of leading-edge technical partners. The ECHO community advocates for children’s health and their access to the best quality care through the collaborative work of children’s hospitals.
The consortium hospital partners are HUS Helsinki University Hospital (Finland), Erasmus Universitair Medisch Centrum Rotterdam (Netherlands), Meyer Children's Hospital IRCCS in Florence (Italy), SJD Barcelona Children’s Hospital (Spain), Great Ormond Street Hospital for Children in London (United Kingdom), Bērnu klīniskā universitātes slimnīca (Latvia) In addition to Childrens’ Hospitals, the PHEMS consortium includes technology partners: Tietoevry Finland Oy (Finland), Aridhia Informatics Limited (UK) and VEIL.AI Oy (Finland) and two professional services partners: The Hyve B.V. (Netherlands) and GENESIS Biomed (Spain). The proposal preparation was supported by company specialized in EU-funding, namely Spinverse.
Keywords
Contacts
Katariina GehrmannDirector of Digital and Innovation ServicesNew Children’s Hospital, HUS Helsinki University Hospital
Tel:+358 40 730 7741katariina.gehrmann@hus.fiImages
About HUS
HUS Helsinki University Hospital is the biggest provider of specialized healthcare in Finland. Our high expertise is internationally recognized and accredited. As a university hospital, we are on the cutting edge of developing and evaluating our treatment methods and activities.
HUS treats almost 700,000 patients every year. Our nearly 27,000 professionals work to provide the best possible care for our patients. We are responsible for organizing specialized health care in the Uusimaa region. The treatment of many rare and difficult diseases in Finland has been centralized to HUS as well.
HUS – Leading healthcare
The HUS media service is available for the media Mon–Thu 10:00 a.m.-4:00 p.m. and Fri 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
Alternative languages
Subscribe to releases from HUS
Subscribe to all the latest releases from HUS by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from HUS
HUS försöker uppnå förbättrad produktivitet7.4.2025 12:22:02 EEST | Pressmeddelande
HUS-sammanslutningens styrelse behandlade verksamheten och ekonomin för januari–februari och beslutade om åtgärder inriktade på en förbättring av produktiviteten.
HUS tavoittelee tuottavuuden parannusta7.4.2025 12:22:02 EEST | Tiedote
HUSin yhtymähallitus käsitteli tammi–helmikuun toimintaa ja taloutta sekä päätti tuottavuuden parantamiseen tähtäävistä toimenpiteistä.
Förhandsmeddelande: HUS-sammanslutningens styrelse sammanträder den 7 april3.4.2025 15:19:49 EEST | Pressmeddelande
HUS-sammanslutningens styrelse sammanträder för att behandla bland annat verksamheten och ekonomin under januari–februari samt en förbättring av produktiviteten.
Ennakkotiedote: HUSin yhtymähallitus kokoontuu 7.4.3.4.2025 15:19:49 EEST | Tiedote
HUSin yhtymähallitus kokoontuu käsittelemään mm. tammi-helmikuun toimintaa ja taloutta sekä tuottavuuden parantamista.
Rekordår för medicinskt assisterade befruktningar på HUS26.3.2025 09:06:49 EET | Pressmeddelande
Antalet remisser, mottagningsbesök och medicinskt assisterade befruktningar ökade tydligt från i fjol. Antalet behandlingar med donerade spermier ökade med över 42 procent. Det råder brist på äggcellsdonatorer.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom